What is CGEN stock price today?

Visit our real-time dashboard for the current CGEN stock price and live market data.

Is CGEN stock going up or down today?

CGEN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CGEN stock now?

The decision to buy CGEN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CGEN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CGEN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CGEN stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CGEN is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CGEN's P/E ratio?

P/E ratio data for CGEN will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CGEN's market cap?

CGEN (Compugen) has a market capitalization of $0.17 billion, making it a small-cap stock.

What is CGEN's price to book ratio?

Price-to-book ratio for CGEN is available on our dashboard along with other valuation metrics.

Does CGEN pay dividends?

CGEN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CGEN's dividend yield?

CGEN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CGEN stock a good long-term investment?

CGEN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CGEN's revenue growth rate?

Revenue growth data for CGEN is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CGEN are available on our dashboard with complete income statement analysis.

What are the risks of investing in CGEN?

Key risks for CGEN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CGEN compare to its competitors?

Compare CGEN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CGEN's performance and positioning.

What is CGEN's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CGEN with bull, base, and bear case scenarios.

What do analysts say about CGEN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CGEN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CGEN's next earnings report?

CGEN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CGEN - Compugen

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Compugen

Compugen (CGEN) common stock

Price Chart

Loading chart...

CGEN Key Statistics

Market Cap

$166.45M

How CGEN Compares to Peers

CGEN is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
CGEN(This stock)	$166.45M	N/A	0%	0.0%	-
AMGNAmgen Inc	$163.61B	27.4	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 5, 2026 at 10:10 PM EDT

Ready to invest in CGEN?

Commission-free trading available. Affiliate links.

Upcoming Events for CGEN

Dashboard

Enter a ticker to analyze